Structure Therapeutics (GPCR) Tax Provisions (2022 - 2026)

Quarterly Tax Provisions rose 93.88% to $190000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $607000.0 through Mar 2026, up 60.16% year-over-year, with the annual reading at $515000.0 for FY2025, 66.13% up from the prior year.

Structure Therapeutics' Tax Provisions history spans 5 years, with the latest figure at $190000.0 for Q1 2026.

  • Tax Provisions came in at $190000.0 for Q1 2026, up from $170000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $405000.0 in Q3 2023 to a low of -$326000.0 in Q4 2023.
  • The 5-year median for Tax Provisions is $92000.0 (2024), against an average of $73764.7.
  • The largest YoY upside for Tax Provisions was 454.79% in 2023 against a maximum downside of 81.11% in 2023.
  • Structure Therapeutics' Tax Provisions stood at -$180000.0 in 2022, then crashed by 81.11% to -$326000.0 in 2023, then surged by 141.72% to $136000.0 in 2024, then rose by 25.0% to $170000.0 in 2025, then grew by 11.76% to $190000.0 in 2026.
  • Per Business Quant, the three most recent readings for GPCR's Tax Provisions are $190000.0 (Q1 2026), $170000.0 (Q4 2025), and $108000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -859,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 221.50 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 104.00 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - 216,000.00
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 15.66 Mn
10 Structure Therapeutics 8.43 Bn 8.43 Bn - 190,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 190,000.00
Dec 31, 2025 170,000.00
Sep 30, 2025 108,000.00
Jun 30, 2025 139,000.00
Mar 31, 2025 98,000.00
Dec 31, 2024 136,000.00
Sep 30, 2024 92,000.00
Jun 30, 2024 53,000.00
Mar 31, 2024 29,000.00
Dec 31, 2023 -326,000.00
Sep 30, 2023 405,000.00
Jun 30, 2023 118,000.00
Mar 31, 2023 25,000.00
Dec 31, 2022 -180,000.00
Sep 30, 2022 73,000.00
Jun 30, 2022 64,000.00
Mar 31, 2022 60,000.00